1. Home
  2. ROIV vs KNX Comparison

ROIV vs KNX Comparison

Compare ROIV & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$41.00

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Logo Knight-Swift Transportation Holdings Inc.

KNX

Knight-Swift Transportation Holdings Inc.

HOLD

Current Price

$67.65

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
KNX
Founded
2014
1989
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
25.1B
11.7B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
ROIV
KNX
Price
$41.00
$67.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
20
Target Price
$28.94
$65.00
AVG Volume (30 Days)
7.9M
2.7M
Earning Date
05-28-2026
04-22-2026
Dividend Yield
N/A
1.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,260,000.00
$7,469,689,000.00
Revenue This Year
N/A
$6.91
Revenue Next Year
$744.61
$7.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.80
52 Week Low
$13.83
$38.63
52 Week High
$42.50
$82.86

Technical Indicators

Market Signals
Indicator
ROIV
KNX
Relative Strength Index (RSI) 66.10 47.29
Support Level $33.15 $66.86
Resistance Level N/A $73.97
Average True Range (ATR) 1.37 2.42
MACD 0.53 0.22
Stochastic Oscillator 78.11 49.93

Price Performance

Historical Comparison
ROIV
KNX

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift Transportation is the largest full-truckload carrier in the US, with a diversified transportation offering. Roughly 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 63% and less than truckload 19%. Truck brokerage and other asset-light logistics services make up 8% of revenue, with intermodal near 5%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue is from services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: